Form 4: Lipocine Inc. Director Richard Dana Ono Reports Stock Option Grant and Disposal

Director Richard Dana Ono reported the acquisition of stock options and disposal of common stock in Lipocine Inc.

Summary

• On June 7, 2024, Richard Dana Ono, a director of Lipocine Inc., filed a Form 4 with the SEC.
• The report details transactions involving Lipocine Inc. [LPCN] securities.
• Ono acquired the right to buy 1,764 shares of common stock at an exercise price of $7.05 on June 5, 2024, exercisable from June 5, 2025, and expiring on June 5, 2035.
• Ono also disposed of 1,764 shares of common stock.
• Following these transactions, Ono beneficially owns 10,938 shares of Lipocine Inc. common stock.
• The options vest 100% one year from the date of grant.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock option grants and disposal. It doesn't inherently convey positive or negative sentiment.

Industry Context

This is a standard SEC filing related to insider transactions. It's common for directors and officers of publicly traded companies to receive stock options as part of their compensation packages. These filings provide transparency into their trading activities.

Stakeholder Impact

• The transaction could have a minor impact on shareholders, as it reflects insider activity.
• The grant of options could incentivize the director to work towards increasing shareholder value.

Key Dates